rs199422123

Variant summary

Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM1BP4_ModerateBS2_Supporting

The NM_002769.5(PRSS1):​c.361G>A​(p.Ala121Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000477 in 1,613,858 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A121V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000051 ( 0 hom. )

Consequence

PRSS1
NM_002769.5 missense

Scores

1
2
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: -4.95
Variant links:
Genes affected
PRSS1 (HGNC:9475): (serine protease 1) This gene encodes a trypsinogen, which is a member of the trypsin family of serine proteases. This enzyme is secreted by the pancreas and cleaved to its active form in the small intestine. It is active on peptide linkages involving the carboxyl group of lysine or arginine. Mutations in this gene are associated with hereditary pancreatitis. This gene and several other trypsinogen genes are localized to the T cell receptor beta locus on chromosome 7. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -1 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 16 uncertain in NM_002769.5
BP4
Computational evidence support a benign effect (MetaRNN=0.14646232).
BS2
High AC in GnomAdExome4 at 74 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PRSS1NM_002769.5 linkuse as main transcriptc.361G>A p.Ala121Thr missense_variant 3/5 ENST00000311737.12

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PRSS1ENST00000311737.12 linkuse as main transcriptc.361G>A p.Ala121Thr missense_variant 3/51 NM_002769.5 P1

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
151978
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000484
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000200
AC:
5
AN:
250602
Hom.:
0
AF XY:
0.0000295
AC XY:
4
AN XY:
135548
show subpopulations
Gnomad AFR exome
AF:
0.0000617
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000506
AC:
74
AN:
1461880
Hom.:
0
Cov.:
61
AF XY:
0.0000536
AC XY:
39
AN XY:
727242
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000629
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
151978
Hom.:
0
Cov.:
31
AF XY:
0.0000135
AC XY:
1
AN XY:
74238
show subpopulations
Gnomad4 AFR
AF:
0.0000484
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000106
Hom.:
0
ExAC
AF:
0.0000412
AC:
5
EpiCase
AF:
0.000273
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary pancreatitis Uncertain:3
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 22, 2023The p.A121T variant (also known as c.361G>A), located in coding exon 3 of the PRSS1 gene, results from a G to A substitution at nucleotide position 361. The alanine at codon 121 is replaced by threonine, an amino acid with similar properties. This alteration was first described in an individual with pancreatitis; however, four family members who carried this variant did not have pancreatitis. The same study found this variant resulted in an increased rate of trypsin cleavage (Felderbauer P et al. J. Med. Genet. 2008; 45:507-12). One study found a significant correlation between individuals who carried this alteration and pancreatitis (Liu QC et al. Chin. Med. J. 2008; 121:108-11). However, an additional study found this variant had no effect on auto-activation, degradation, secretion, or kinetic parameters of trypsin (Szmola R and Sahin-Tóth M J. Med. Genet. 2010; 47:348-50). This amino acid position is poorly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Uncertain significance, no assertion criteria providedliterature onlyOMIMMay 01, 2010- -
Uncertain significance, criteria provided, single submitterclinical testingInvitaeJan 06, 2024This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 121 of the PRSS1 protein (p.Ala121Thr). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with chronic pancreatitis (PMID: 16791840, 18272034, 18511571, 20001681). ClinVar contains an entry for this variant (Variation ID: 11885). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PRSS1 protein function with a negative predictive value of 80%. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on PRSS1 function (PMID: 18511571, 20452997). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 01, 2023Variant summary: PRSS1 c.361G>A (p.Ala121Thr) results in a non-conservative amino acid change located in the Serine proteases, trypsin domain (IPR001254) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 250602 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.361G>A has been reported in the literature in individuals affected with Chronic Pancreatitis, however does not appear to segregate with the disease (examples: Felderbauer_2008, Liu_2008, Liu_PRSS1_2009 and Szmola_2010) . These report(s) do not provide unequivocal conclusions about association of the variant with Chronic Pancreatitis. Multiple publications have reported experimental evidence evaluating an impact on protein function. These results showed conflicting asessments on variant function (example: Felderbauer_2008 and Szmola_2010). The following publications have been ascertained in the context of this evaluation (PMID: 18511571, 20001681, 18272034, 20452997 ). Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxFeb 10, 2020Published functional studies demonstrate no impact on autoactivation or secretion rates and conflicting results on degradation (Felderbauer 2008, Szmola 2010); Observed in individuals with a personal history of pancreatitis, but also in unaffected relatives (Felderbauer 2008, Liu 2008); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 18511571, 20452997, 18272034, 18946221, 20001681, 16791840) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Pathogenic
0.16
D
BayesDel_noAF
Uncertain
0.0
CADD
Benign
0.065
DANN
Benign
0.93
DEOGEN2
Benign
0.34
.;.;T;T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.010
N
M_CAP
Benign
0.044
D
MetaRNN
Benign
0.15
T;T;T;T
MetaSVM
Benign
-0.59
T
MutationAssessor
Benign
0.43
.;.;N;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.60
N;.;N;N
REVEL
Uncertain
0.52
Sift
Benign
0.092
T;.;T;T
Sift4G
Benign
0.36
T;T;T;T
Polyphen
0.0050
B;.;B;.
Vest4
0.65
MVP
0.51
MPC
0.16
ClinPred
0.035
T
GERP RS
-6.6
Varity_R
0.11
gMVP
0.46

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199422123; hg19: chr7-142459785; COSMIC: COSV61197755; COSMIC: COSV61197755; API